The FDA’s latest move to warn about the Ortho Evra Patch risks
The U. S. Food and Drug Administration is harnessing the power of the internet in an effort to inform tech and online savvy folk of any complications or health concerns such as those experienced after using a defective drug or product. Their most recent post was targeted at young women between the ages of 15 and 44. Almost two months ago a YouTube video was targeted at warning this population of the dangers of venous thromboembolism and the use of the Ortho Evra Patch. So far three such videos have been posted. This is the latest move by the FDA in a campaign to improve public awareness about the dangers of the patch. The videos include information about two studies done previously that show an increased risk for life-threatening side effects among women aged 15 through 44. The more recent YouTube video focuses on the recent label changes brought about by the two studies, both of which show that women in this age group are at an increased risk for blood clots. The YouTube video also encourages women to talk to their health care provider before electing to use the patch. The question remains whether this latest move by the FDA will be effective enough in protecting future young women. According to the YouTube presentation, the video has only been seen 113 times since it was posted July 2 and that includes the visit that brought about this blog. TV commercials have not been informative enough in explaining the risks. It would seem that women are still finding out about the dangers after they have already been to the hospital for treatment of the side effects. ">Ortho Evra Patch. So far three such videos have been posted. This is the latest move by the FDA in a campaign to improve public awareness about the dangers of the patch. The videos include information about two studies done previously that show an increased risk for life-threatening side effects among women aged 15 through 44. The more recent YouTube video focuses on the recent label changes brought about by the two studies, both of which show that women in this age group are at an increased risk for blood clots. The YouTube video also encourages women to talk to their health care provider before electing to use the patch. The question remains whether this latest move by the FDA will be effective enough in protecting future young women. According to the YouTube presentation, the video has only been seen 113 times since it was posted July 2 and that includes the visit that brought about this blog. TV commercials have not been informative enough in explaining the risks. It would seem that women are still finding out about the dangers after they have already been to the hospital for treatment of the side effects.




